<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203070</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1998-3689</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Indian journal of ophthalmology</Title><ISOAbbreviation>Indian J Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Posterior segment involvement in systemic lupus erythematosus - A series from South India.</ArticleTitle><Pagination><StartPage>1986</StartPage><EndPage>1993</EndPage><MedlinePgn>1986-1993</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/ijo.IJO_1705_22</ELocationID><Abstract><AbstractText Label="PURPOSE">To report the spectrum of posterior segment manifestations and visual outcomes in a large series of patients with systemic lupus erythematosus (SLE).</AbstractText><AbstractText Label="METHODS">Retrospective study at a tertiary referral eye center in south India between 2016 and 2022.</AbstractText><AbstractText Label="RESULTS">Charts of 109 patients diagnosed to have SLE were retrieved from our medical database. Only nine cases of SLE (8.25%) had posterior segment involvement. The male: female ratio was 1:8. The mean age was 28 years. Unilaterality was the most common presentation in eight cases (88.89%). Lupus nephritis was the most common systemic presentation in five cases (55.56%). Antiphospholipid antibodies (APLA) positivity was seen in two cases (22.22%). Ocular manifestations included microangiopathy (cotton wool spots) in one case, occlusive retinal vasculitis with cotton wool spots in four cases (five eyes), optic disc edema with combined venous and arterial occlusion (one case), central retinal vein occlusion with cotton wool spots and hemorrhages (one case), macular edema (four cases), posterior scleritis with optic disc edema and exudative retinal detachment in the posterior pole (one case), and tubercular choroidal granuloma (one case). Treatment included systemic steroids, hydroxychloroquine sulfate (HCQS), and immunosuppression in all cases, blood thinners in two cases, and laser photocoagulation in four cases. HCQS-related retinal toxicity was not seen in any of the 109 cases. Ocular manifestation was the initial presentation of SLE in one case. Visual outcome was poor in three cases.</AbstractText><AbstractText Label="CONCLUSION">Presence of posterior segment findings in cases with SLE may suggest a severe systemic disease. Early detection and aggressive treatment result in better visual outcomes. Ophthalmologists could play a vital role in guiding systemic therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Kalpana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Uvea and Ocular Inflammation, Prabha Eye Clinic and Research Centre and Vittala International Institute of Ophthalmology, Bengaluru, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanda</LastName><ForeName>Satabdi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vitreoretinal Services, Vittala International Institute of Ophthalmology, Bengaluru, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegde</LastName><ForeName>Preeti</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Uvea and Ocular Inflammation, Prabha Eye Clinic and Research Centre and Vittala International Institute of Ophthalmology, Bengaluru, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Anand P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jois</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Manipal Hospitals, Bengaluru, Karnataka, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Ophthalmol</MedlineTA><NlmUniqueID>0405376</NlmUniqueID><ISSNLinking>0301-4738</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010211" MajorTopicYN="Y">Papilledema</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005128" MajorTopicYN="Y">Eye Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012170" MajorTopicYN="Y">Retinal Vein Occlusion</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lupus retinopathy</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">macular ischemia</Keyword><Keyword MajorTopicYN="N">ocular manifestations</Keyword><Keyword MajorTopicYN="N">posterior scleritis</Keyword></KeywordList><CoiStatement>None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203070</ArticleId><ArticleId IdType="pmc">PMC10391432</ArticleId><ArticleId IdType="doi">10.4103/ijo.IJO_1705_22</ArticleId><ArticleId IdType="pii">IndianJOphthalmol_2023_71_5_1986_376949</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus. 1993;2:115&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8330032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB. Severe retinal vaso- Occlusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1986;104:558&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">3954661</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum. 1988;31:1105&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">3422014</ArticleId></ArticleIdList></Reference><Reference><Citation>Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100:135&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">25904124</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against Rheumatism/American College of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Iba&#xf1;ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision) Ophthalmology. 2016;123:1386&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">26992838</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol. 2016;30:117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4908056</ArticleId><ArticleId IdType="pubmed">27330388</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies JB, Rao PK. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2008;19:512&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18998618</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammacco R, Procaccio P, Racanelli V, Vacca A, Dammacco F. Ocular involvement in systemic lupus erythematosus: The experience of two tertiary referral centers. Ocul Immunol Inflamm. 2018;26:1154&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">30096011</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias-Santos A, Tavares Ferreira J, Pinheiro S, Cunha J, Alves M, Papoila A, et al. Ocular involvement in systemic lupus erythematosus patients: A paradigm shift based on the experience of a tertiary referral center. Lupus. 2020;29:283&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31992127</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitaula R, Shah DN, Singh D. The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal. Ocul Immunol Inflamm. 2011;19:422&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106910</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth G, Chengappa KG, Misra DP, Babu R, Belani P, Shanoj KC, et al. Lupus retinopathy: A marker of active systemic lupus erythematosus. Rheumatol Int. 2018;38:1495&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">29948002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nangia PV, Viswanathan L, Kharel R, Biswas J. Retinal involvement in systemic lupus erythematosus. Lupus Open Access. 2017;2:1000129.</Citation></Reference><Reference><Citation>Lanham JG, Barrie T, Kohner EM, Hughes GR. SLE retinopathy: Evaluation by fluorescein angiography. Ann Rheum Dis. 1982;41:473&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1001025</ArticleId><ArticleId IdType="pubmed">7125716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashiri H, Karimi N, Mostafaei S, Baghdadi A, Nejadhosseinian M, Faezi ST. Retinopathy in newly-diagnosed systemic lupus erythematosus: Should we screen for ocular involvement? BMC Rheumatol. 2021;5:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8485475</ArticleId><ArticleId IdType="pubmed">34593048</ArticleId></ArticleIdList></Reference><Reference><Citation>Monov S, Hristova R, Dacheva R, Toncheva R, Shumnalieva R, Shoumnalieva-Ivanova V, et al. Acute necrotizing retinal vasculitis as onset of systemic lupus erythematosus: A case report. Medicine (Baltimore) 2017;96:e5754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5266163</ArticleId><ArticleId IdType="pubmed">28079801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizaki J, Saito K, Nawata M, Mizuno Y, Tokunaga M, Sawamukai N, et al. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2015;54:405&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">25183834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>